<REC r_id_disclaimer='ResearcherID data provided by Clarivate Analytics'>
  <UID>MEDLINE:24452614</UID>
  <static_data>
    <summary>
      <EWUID>
        <WUID coll_id='MEDLINE'/>
        <edition value='MEDLINE.MEDLINE'/>
      </EWUID>
      <pub_info coverdate='2014-Jan-22' edate='2014-01-22' has_abstract='Y' medium='Print' model='Electronic' pubday='22' pubmonth='Jan' pubtype='Journal' pubyear='2014' sortdate='2014-01-22' vol='3'>
        <page begin='e93'>e93</page>
      </pub_info>
      <titles count='4'>
        <title type='item'>
          Identifying druggable targets by protein microenvironments matching:
          application to transcription factors.
        </title>
        <title type='source'>CPT: pharmacometrics &amp; systems pharmacology</title>
        <title type='abbrev_iso'>CPT Pharmacometrics Syst Pharmacol</title>
        <title type='source_abbrev'>CPT Pharmacometrics Syst Pharmacol</title>
      </titles>
      <names count='2'>
        <name display='Y' role='author' seq_no='1'>
          <display_name>Liu, T</display_name>
          <full_name>Liu, T</full_name>
          <initials>T</initials>
        </name>
        <name display='Y' role='author' seq_no='2'>
          <display_name>Altman, R B</display_name>
          <full_name>Altman, R B</full_name>
          <initials>RB</initials>
        </name>
      </names>
      <doctypes count='1'>
        <doctype>Journal Article</doctype>
      </doctypes>
    </summary>
    <fullrecord_metadata>
      <languages count='1'>
        <language type='primary'>English</language>
      </languages>
      <normalized_languages count='1'>
        <language type='primary'>English</language>
      </normalized_languages>
      <normalized_doctypes count='1'>
        <doctype>Article</doctype>
      </normalized_doctypes>
      <addresses count='1'>
        <address_name>
          <address_spec addr_no='1'>
            <full_address>Department of Genetics, Stanford University, Stanford, California, USA.</full_address>
          </address_spec>
        </address_name>
      </addresses>
      <fund_ack>
        <grants complete='Y' count='3'>
          <grant>
            <grant_agency>NIGMS NIH HHS</grant_agency>
            <grant_ids count='1'>
              <grant_id>R01 GM102365</grant_id>
            </grant_ids>
            <country>United States</country>
            <acronym>GM</acronym>
          </grant>
          <grant>
            <grant_agency>NLM NIH HHS</grant_agency>
            <grant_ids count='1'>
              <grant_id>R01 LM005652</grant_id>
            </grant_ids>
            <country>United States</country>
            <acronym>LM</acronym>
          </grant>
          <grant>
            <grant_agency>NIGMS NIH HHS</grant_agency>
            <grant_ids count='1'>
              <grant_id>U54 GM072970</grant_id>
            </grant_ids>
            <country>United States</country>
            <acronym>GM</acronym>
          </grant>
        </grants>
      </fund_ack>
      <abstracts count='1'>
        <abstract>
          <abstract_text>
            <p>
              Druggability of a protein is its potential to be modulated by
              drug-like molecules. It is important in the target selection
              phase. We hypothesize that: (i) known drug-binding sites contain
              advantageous physicochemical properties for drug binding, or
              "druggable microenvironments" and (ii) given a target, the
              presence of multiple druggable microenvironments similar to those
              seen previously is associated with a high likelihood of
              druggability. We developed DrugFEATURE to quantify druggability by
              assessing the microenvironments in potential small-molecule
              binding sites. We benchmarked DrugFEATURE using two data sets. One
              data set measures druggability using NMR-based screening.
              DrugFEATURE correlates well with this metric. The second data set
              is based on historical drug discovery outcomes. Using the
              DrugFEATURE cutoffs derived from the first, we accurately
              discriminated druggable and difficult targets in the second. We
              further identified novel druggable transcription factors with
              implications for cancer therapy. DrugFEATURE provides useful
              insight for drug discovery, by evaluating druggability and
              suggesting specific regions for interacting with drug-like
              molecules.CPT: Pharmacometrics Systems Pharmacology (2014) 3, e93;
              doi:10.1038/psp.2013.66; published online 22 January 2014.
            </p>
          </abstract_text>
        </abstract>
      </abstracts>
    </fullrecord_metadata>
    <item xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' Owner='NLM' Status='PubMed-not-MEDLINE' coll_id='MEDLINE' xsi:type='itemType_medline'>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <NlmUniqueID>101580011</NlmUniqueID>
        <ISSNLinking>2163-8306</ISSNLinking>
      </MedlineJournalInfo>
      <DateCreated>2014-01-23</DateCreated>
      <DateCompleted>2014-01-23</DateCompleted>
      <DateRevised>2016-10-19</DateRevised>
      <Affiliation>Department of Genetics, Stanford University, Stanford, California, USA.</Affiliation>
      <OtherID Source='NLM'>PMC3910014</OtherID>
    </item>
  </static_data>
  <dynamic_data>
    <citation_related>
      <tc_list>
        <silo_tc coll_id='MEDLINE' local_count='0'/>
      </tc_list>
    </citation_related>
    <cluster_related>
      <identifiers>
        <identifier type='doi' value='10.1038/psp.2013.66'/>
        <identifier type='pmid' value='MEDLINE:24452614'/>
      </identifiers>
    </cluster_related>
  </dynamic_data>
</REC>
